Based on the measurements of operating efficiency obtained from Milestone Scientific's historical financial statements, Milestone Scientific is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December. At this time, Milestone Scientific's Common Stock is comparatively stable compared to the past year. Property Plant Equipment is likely to gain to about 542.6 K in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 376.2 K in 2024. Key indicators impacting Milestone Scientific's financial strength include:
The financial analysis of Milestone Scientific is a critical element in measuring its lifeblood. Investors should not minimize Milestone Scientific's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
(7.28 Million)
Milestone
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
End Period Cash Flow
Total Cash From Financing Activities
Sale Purchase Of Stock
Change To Liabilities
Change To Account Receivables
Stock Based Compensation
Change Receivables
Total Cashflows From Investing Activities
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Other Cashflows From Investing Activities
Change To Netincome
Investments
Net Borrowings
Change To Operating Activities
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Inventory
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Short Term Debt
Intangible Assets
Other Current Assets
Accumulated Other Comprehensive Income
Common Stock Total Equity
Non Current Liabilities Total
Common Stock
Other Assets
Long Term Debt
Treasury Stock
Property Plant Equipment
Other Liab
Current Deferred Revenue
Net Tangible Assets
Total Permanent Equity
Noncontrolling Interest In Consolidated Entity
Retained Earnings Total Equity
Short Term Investments
Capital Surpluse
Additional Paid In Capital
Long Term Investments
Net Invested Capital
Net Working Capital
Capital Stock
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Cost Of Revenue
Net Income From Continuing Ops
Non Operating Income Net Other
Net Income Applicable To Common Shares
Minority Interest
Tax Provision
Interest Income
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Milestone Scientific Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Milestone Scientific's financial statements are interrelated, with each one affecting the others. For example, an increase in Milestone Scientific's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Milestone Scientific's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Milestone Scientific. Check Milestone Scientific's Beneish M Score to see the likelihood of Milestone Scientific's management manipulating its earnings.
Milestone Scientific Stock Summary
Milestone Scientific competes with InfuSystems Holdings, STRATA Skin, Retractable Technologies, OncoCyte Corp, and PAVmed. Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey. Milestone Scientific operates under Medical Instruments Supplies classification in the United States and is traded on AMEX Exchange. It employs 26 people.
Milestone Scientific Key Income Statement Accounts
The reason investors look at the income statement is to determine what Milestone Scientific's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Milestone Scientific's current stock value. Our valuation model uses many indicators to compare Milestone Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Milestone Scientific competition to find correlations between indicators driving Milestone Scientific's intrinsic value. More Info.
Milestone Scientific is regarded third in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . At this time, Milestone Scientific's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Milestone Scientific by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Milestone Scientific Systematic Risk
Milestone Scientific's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Milestone Scientific volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Milestone Scientific correlated with the market. If Beta is less than 0 Milestone Scientific generally moves in the opposite direction as compared to the market. If Milestone Scientific Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Milestone Scientific is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Milestone Scientific is generally in the same direction as the market. If Beta > 1 Milestone Scientific moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Milestone Scientific Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Milestone Scientific's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Milestone Scientific growth as a starting point in their analysis.
Milestone Scientific November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Milestone Scientific help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Milestone Scientific. We use our internally-developed statistical techniques to arrive at the intrinsic value of Milestone Scientific based on widely used predictive technical indicators. In general, we focus on analyzing Milestone Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Milestone Scientific's daily price indicators and compare them against related drivers.
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.